The overall objective of this study is to increase the number of dark skin tone individuals in the data set and evaluate if this increase in dark skin tone data has an impact on the accuracy of the SCOUT DS Diabetes Risk Score (DRS).
Study Type
OBSERVATIONAL
Enrollment
196
Radiant Research
Birmingham, Alabama, United States
Radiant Research
Atlanta, Georgia, United States
Radiant Research
Chicago, Illinois, United States
Accelovance
Rockville, Maryland, United States
Radiant Research
Validation of the SCOUT DS algorithm comparing it to Oral Glucose Tolerance Test in dark skinned individuals
The primary study endpoint is the relative true positive and relative true negative fractions between the SCOUT DS and FPG test for detecting abnormal glucose tolerance (2 hr OGTT value ≥ 140 mg/dL).
Time frame: 6 months
Compare SCOUT DS and FPG to HbA1c
Secondary endpoint is to evaluate the receiver operator characteristic area under the curve, sensitivity, specificity, and positive (PPV) and negative (NPV) predictive values of SCOUT DS, FPG, and A1C test for detection of abnormal glucose tolerance.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Kansas City, Missouri, United States